Cargando...
Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
Dysregulated fibroblast growth factor receptor (FGFR) signaling is associated with several cancers, including urothelial carcinoma. Preclinical studies with FGFR inhibitors have shown significant antitumor activity, which has led to clinical evaluation of multiple FGFR inhibitors. Recently, erdafiti...
Guardado en:
| Publicado en: | Oncologist |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648343/ https://ncbi.nlm.nih.gov/pubmed/32790011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0334 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|